Activity

A Drug Called Ribociclib Can, For The First Time, Slow The Progression Of Advanced Breast Cancer, And Extend The Survival OF 70% Of Women, Who Developed The Disease Before Or During Menopause, By 3.5 Yrs. But That’s When Taken With Standard Treatment. This’s 25% More Lives Prolonged Than Using Standard Treatment Alone.

Breast cancer treatment: Drug Kisqali (ribociclib) extends lives of young breast cancer patients, study finds – CBS News

https://www.cbsnews.com/news/breast-cancer-treatment-drug-ribociclib-extends-lives-of-young-breast-cancer-patients-study-finds/

The drug Kisqali (ribociclib) is already approved by the FDA, and new research shows it helps some breast cancer patients live longer